Morningstar (MORN) PT Raised to $212 at BMO Capital

BMO Capital analyst Jeffrey Silber raised the price target on Morningstar (NASDAQ: MORN) to $212.00 (from $205.00) while maintaining a Outperform rating.

The analyst commented, "1Q26 results beat expectations, driven by Credit and AOI margin outperformance. Organic growth decelerated 50bp (mostly in Direct Platform and PitchBook), though we believe some of this was expected. MORN Credit was the clear outperformer once again with broad-based strength driving meaningful operating leverage in 1Q26. MORN was highly active in repurchases during the quarter, buying back about 4% of year-end shares o/s. The current NTM EV/EBITDA multiple was last reached in 2009; we believe the Gen-AI disruption selloff is overdone. We raise our estimates and target."

You May Also Be Interested In

• Lake Street Starts Vivani Medical, Inc. (VANI) at Buy
• Range Resources (RRC) PT Lowered to $53 at Stephens
• JPMorgan Downgrades Metcash Ltd. (MTS:AU) (MHTLY) to Neutral